A big week starts with this growing biotech play
Published: Mon, 03/06/17
 SMS alerts can make the difference between a profitable trade and a missed opportunity. Text “alert” to 97000 to receive our instant, reliable and free SMS alerts. Hello fellow investors / traders, We are focusing on OBMP today, a hot biotech ticker.
In fact, members will remember I first alerted OBMP on 20 January. It opened at $0.20 and hit $0.25 that same day on big volume for a 25% gain. Even more impressive was that it went on to breakout in a big way, hitting a six month high of $0.42 just a few weeks later, for over 100% gains from our alert price. OBMP closed at around $0.32 on Friday. I was watching level 2 and it appeared to have a ton of support at $0.30. That's why I think we see another push to the upside this week. For those newer members, my view on OBMP remains the same, and here it is... Biotech has been one of the hottest sector in 2017, and it shows no signs of slowing down yet. Many small cap biotech's have been running 100, 200, even 1,000%+ in a matter of days. This sector is on fire, and with recent strong momentum, OBMP continues to show tremendous strength amidst a technical breakout. Actually, OBMP has one of the hottest charts in the entire market. A few weeks ago OBMP broke through recent highs and it hasn't looked back since. And the popular trading website Barchart.com concurs, rating OBMP a buy on every time frame - short, medium and long term. In addition, OBMP has excellent recent volume and liquidity, a tight level 2, and a small market cap and float, as it has steadily climbed higher over the past week or so. So what's the catalyst for this breakout move higher? OBMP has recently been announcing some major news regarding ProscaVax, its novel therapeutic cancer vaccine. Last month, OBMP announced that the Company's abstract illustrating research on its novel therapeutic cancer vaccine, has been accepted for a poster presentation at the American Association for Cancer Research (AACR) Annual Meeting 2017 in Washington, D.C. Just over a month ago, OBMP provided the latest clinical data of ProscaVax, the Company's novel therapeutic prostate cancer vaccine. In January, OBMP announced the receipt of acknowledgement and authorization to perform the protocol proposed for the Phase 2/3 clinical trial of ProscaVax from the Department of Urology of the High Specialty Hospital IMSS Siglo XXI ("HSH IMSS") in Mexico. And before this, OBMP announced that its upcoming Phase 2 trial of ProscaVax, a novel therapeutic cancer vaccine, is a prime candidate for submission to the Cancer Therapy Evaluation Program (CTEP) at the National Cancer Institute. These are some impressive and major catalysts for a company with a market cap of less than $20m. OncBioMune Pharmaceuticals (OBMP) is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a proprietary Vaccine Technology that is designed to stimulate the immune system to attack its own cancer while not hurting the patient. The Company's lead product, ProscaVax™ for prostate cancer, is near conclusion of a Phase 1 trial funded by the Department of Defense Navy Cancer Vaccine Program. Based upon data showing ProscaVax is non-toxic and can lower PSA levels, they are moving ProscaVax into a Phase 2 trial for prostate cancer patients in the “Active Surveillance” category, an early stage of disease for which there are currently no treatments without significant morbidities. OncBioMune also has a portfolio of targeted therapies, some of which are biosimilars to blockbuster drugs. The prostate cancer market is a $7.1B market right now, and unfortunately one that is growing fast. OBMP is a company that could have an answer . The company's recent press releases are a signal to the world that the company has arrived, and is rapidly gaining traction on finding a much needed solution for this terrible disease. We urge you to get OBMP on your screen now and do your research. There is plenty of information on their website and around the internet, including Yahoo! Finance and many other finance portals. OBMP has a ton of momentum on its side. With a breakout chart in full force, and great recent liquidity and volume, a tight level 2, major recent catalysts and an extremely hot sector, this is and could continue to be the perfect trading storm. Happy trading. To your success,
SmallCapMomo.com--------------------------------------------------------------------------------------------------------
Remember our key trading rules when trading. Capital preservation is key. Keep your stops tight, and if things don't go your way, cut your losses and look for another opportunity.
Disclaimer Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. SmallCapMomo.com employees are not registered as an Investment Adviser in any jurisdiction whatsoever. The disclaimer is to be read and fully understood before using our site, or joining our email list. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead SmallCapMomo.com strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. SmallCapMomo.com does not offer such advice or analysis, and SmallCapMomo.com further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor's investment may be lost or impaired due to the speculative nature of the companies profiled. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be "forward looking statements". Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as "projects", "foresee", "expects", "will", "anticipates", "estimates", "believes", "understands", or that by statements indicating certain actions "may", "could", or "might" occur. Understand there is no guarantee past performance will be indicative of future results. In preparing this publication, SmallCapMomo.com has relied upon information supplied by its customers, and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, SmallCapMomo.com and its owners, affiliates, subsidiaries, officers, directors, representatives and agents have not completed any due diligence or research on the companies advertised herein and disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. SmallCapMomo.com is not responsible for any claims made by the companies advertised herein. SmallCapMomo.com may receive compensation and its employees and affiliates may own stock that they have purchased in the open market either prior, during, or after the release of the companies profile which is an inherent conflict of interest in SmallCapMomo.com statements and opinions and such statements and opinions cannot be considered independent. SmallCapMomo.com reserves the right to buy and sell shares of the profiled company on the open market before, during or after the release of the company profile. In such an event, SmallCapMomo.com will not update its disclaimer to reflect any shares bought or sold on the open market during the profile coverage. SmallCapMomo.com and its management may benefit from any increase in the share price of the profiled companies and hold the right to sell the shares bought at any given time including shortly after the release of the companies profile. SmallCapMomo.com has been compensated three thousand dollars via electronic transfer from a non-affiliated third party for the profile of OBMP. SmallCapMomo.com was previously compensated two thousand five hundred dollars via electronic transfer from a non-affiliated third party for the profile of OBMP. SmallCapMomo.com may on occasion accept compensation in restricted or free-trading shares for it's marketing services of the company being profiled, and the third party that might have compensated SmallCapMomo.com may hold free-trading shares of the company being profiled and could very well be selling shares of the companies stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration. If SmallCapMomo.com ever accepts compensation in the form of restricted or free trading shares of the company being profiled and decides to sell these shares into the public market at any time before, during, or after the release of the companies profile our disclaimer will be updated accordingly reflecting the current position of those free trading shares received as compensation for our services. |